181 related articles for article (PubMed ID: 34356612)
21. Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes.
Canning P; Kenny BA; Prise V; Glenn J; Sarker MH; Hudson N; Brandt M; Lopez FJ; Gale D; Luthert PJ; Adamson P; Turowski P; Stitt AW
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7213-8. PubMed ID: 27298369
[TBL] [Abstract][Full Text] [Related]
22. VEGF164 is proinflammatory in the diabetic retina.
Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
[TBL] [Abstract][Full Text] [Related]
23. PKCζ mediates breakdown of outer blood-retinal barriers in diabetic retinopathy.
Omri S; Behar-Cohen F; Rothschild PR; Gélizé E; Jonet L; Jeanny JC; Omri B; Crisanti P
PLoS One; 2013; 8(11):e81600. PubMed ID: 24312324
[TBL] [Abstract][Full Text] [Related]
24. Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy.
Yokomizo H; Maeda Y; Park K; Clermont AC; Hernandez SL; Fickweiler W; Li Q; Wang CH; Paniagua SM; Simao F; Ishikado A; Sun B; Wu IH; Katagiri S; Pober DM; Tinsley LJ; Avery RL; Feener EP; Kern TS; Keenan HA; Aiello LP; Sun JK; King GL
Sci Transl Med; 2019 Jul; 11(499):. PubMed ID: 31270273
[TBL] [Abstract][Full Text] [Related]
25. The emerging roles of clusterin on reduction of both blood retina barrier breakdown and neural retina damage in diabetic retinopathy.
Zhang C; Nie J; Feng L; Luo W; Yao J; Wang F; Wang H
Discov Med; 2016 Apr; 21(116):227-37. PubMed ID: 27232509
[TBL] [Abstract][Full Text] [Related]
26. IL-10-induced modulation of macrophage polarization suppresses outer-blood-retinal barrier disruption in the streptozotocin-induced early diabetic retinopathy mouse model.
Lee SJ; Noh SE; Jo DH; Cho CS; Park KS; Kim JH
FASEB J; 2024 May; 38(9):e23638. PubMed ID: 38713098
[TBL] [Abstract][Full Text] [Related]
27. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.
Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M
Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902
[TBL] [Abstract][Full Text] [Related]
28. Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration.
de Gooyer TE; Stevenson KA; Humphries P; Simpson DA; Gardiner TA; Stitt AW
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5561-8. PubMed ID: 17122149
[TBL] [Abstract][Full Text] [Related]
29. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
[TBL] [Abstract][Full Text] [Related]
30. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
31. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina.
Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M
Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836
[TBL] [Abstract][Full Text] [Related]
32. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
[TBL] [Abstract][Full Text] [Related]
33. Administration of pigment epithelium-derived factor delivered by adeno-associated virus inhibits blood-retinal barrier breakdown in diabetic rats.
Yu H; Chen L; Jiang J
Mol Vis; 2010 Nov; 16():2384-94. PubMed ID: 21139695
[TBL] [Abstract][Full Text] [Related]
34. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
[TBL] [Abstract][Full Text] [Related]
35. Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.
Wisniewska-Kruk J; van der Wijk AE; van Veen HA; Gorgels TG; Vogels IM; Versteeg D; Van Noorden CJ; Schlingemann RO; Klaassen I
Am J Pathol; 2016 Apr; 186(4):1044-54. PubMed ID: 26878208
[TBL] [Abstract][Full Text] [Related]
36. Drp1-dependent mitochondrial fragmentation mediates photoreceptor abnormalities in type 1 diabetic retina.
Tang S; Huang M; Wang R; Li M; Dong N; Wu R; Chi Z; Gao L
Exp Eye Res; 2024 May; 242():109860. PubMed ID: 38467174
[TBL] [Abstract][Full Text] [Related]
37. PHD2 attenuates high-glucose-induced blood retinal barrier breakdown in human retinal microvascular endothelial cells by regulating the Hif-1α/VEGF pathway.
Li J; Lu X; Wei L; Ye D; Lin J; Tang X; Cui K; Yu S; Xu Y; Liang X
Inflamm Res; 2022 Jan; 71(1):69-79. PubMed ID: 34773469
[TBL] [Abstract][Full Text] [Related]
38. VEGF Mediates Retinal Müller Cell Viability and Neuroprotection through BDNF in Diabetes.
Le YZ; Xu B; Chucair-Elliott AJ; Zhang H; Zhu M
Biomolecules; 2021 May; 11(5):. PubMed ID: 34068807
[TBL] [Abstract][Full Text] [Related]
39. Hyperactivation of retina by light in mice leads to photoreceptor cell death mediated by VEGF and retinal pigment epithelium permeability.
Cachafeiro M; Bemelmans AP; Samardzija M; Afanasieva T; Pournaras JA; Grimm C; Kostic C; Philippe S; Wenzel A; Arsenijevic Y
Cell Death Dis; 2013 Aug; 4(8):e781. PubMed ID: 23990021
[TBL] [Abstract][Full Text] [Related]
40. Ursodeoxycholic acid ameliorates diabetic retinopathy via reducing retinal inflammation and reversing the breakdown of blood-retinal barrier.
Ouyang H; Mei X; Zhang T; Lu B; Ji L
Eur J Pharmacol; 2018 Dec; 840():20-27. PubMed ID: 30268667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
